# VALRUBICIN
> **ANDA206430** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2019-04-19
## Drug
- **FDA Application Number:** ANDA206430
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALRUBICIN
- **Generic name:** VALRUBICIN INTRAVESICAL SOLUTION
- **Active ingredients:** VALRUBICIN
- **Dosage form:** SOLUTION
- **Route:** INTRAVESICAL
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2019-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206430)
---
*AI Analytics · CC0 1.0*